Vincent Bauchau

20 Fleming Avenue
Waver, VLG 1300, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspective.

The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspective.

Journal: Frontiers in drug safety and regulation

Published: June 20, 2025

Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices.

Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices.

Journal: Frontiers in drug safety and regulation

Published: June 20, 2025

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.

Journal: Drug safety

Published: December 10, 2024

The Brighton collaboration standardized module for vaccine benefit-risk assessment.

The Brighton collaboration standardized module for vaccine benefit-risk assessment.

Journal: Vaccine

Published: August 24, 2023

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities.

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities.

Journal: Drug safety

Published: March 06, 2023

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).

Journal: Drug safety

Published: September 12, 2020

Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines.

Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines.

Journal: Drug safety

Published: September 11, 2020

ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.

ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.

Journal: Vaccine

Published: April 01, 2019

Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.

Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.

Journal: PloS one

Published: March 20, 2019

ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.

ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.

Journal: Vaccine

Published: January 15, 2019

ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.

ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.

Journal: Vaccine

Published: November 21, 2018

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.

Journal: Vaccine

Published: October 12, 2018

Showing 1-12 of 33

Last Updated: 09/26/2026